In contrast, CCR5-/- mice treated with 4NQO exhibited a reduced incidence of tumour formation (Figure 2J) and lower histopathological scores (Figure 2K and 2M), which was similar to the CCL3-/- mice (Figure 2M). The gene discussed is CCR5; the disease is neoplasm.